Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating)’s share price rose 8.5% on Tuesday . The company traded as high as $6.25 and last traded at $6.23. Approximately 1,791,792 shares traded hands during trading, a decline of 16% from the average daily volume of 2,130,646 shares. The stock had previously closed at $5.74. Wall Street Analyst […]
Eversept Partners LP increased its position in shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating) by 13.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,200,999 shares of the biotechnology company’s stock after acquiring an additional 265,174 shares during the quarter. Seres […]
Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating) has received an average rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The […]